Metabolic Signatures and Biomarkers in Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2011

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

Aripiprazole for 4 weeks

DRUG

Risperidone

Subjects will be randomized to risperidone for 4 weeks

OTHER

Healthy volunteers

Healthy volunteers

Trial Locations (1)

27509

John Umstead Hospital, Butner

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Duke University

OTHER